Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Medbox, Inc. Interviewed On BBC Radio Regarding Medical Marijuana Policy

HOLLYWOOD, Calif., Jan. 9, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) ( www.medboxinc.com), announced that a radio interview was conducted by BBC in the UK with one of the company's founders regarding medical marijuana policy as well as the company's recent stock price surge.

During the interview, which ran live at 10:20 am PST yesterday, Vincent Mehdizadeh, Founder and Senior Consultant at Medbox, Inc, commented, "As we all step back from the proverbial fiscal cliff in the US and a stagnant global economy, it's important that governments worldwide explore new tax bases that are gaining momentum. As such, Medical Marijuana should be given serious consideration as a burgeoning industry."

The company was also asked about its position on the recent outright marijuana legalizations in the US States of Washington and Colorado for recreational use. Medbox commented that while recreational legalizations appear to be gaining traction in some US jurisdictions, the company's focus remains on helping medical marijuana dispensaries operate in accordance with their states' laws. However, the company also confirmed that its technology, used behind-the-counter and at an operators' discretion, can also be utilized in retail businesses in recreational marijuana jurisdictions to assist with inventory control and accurate tax reporting.

The company was also interviewed yesterday by a Chilean journalist with "La Segunda" newspaper in Chile regarding Medbox's international aspirations as to spreading its medicine dispensing technology on a global level. The company confirmed with that reporter that 24-hour access to medical marijuana is not allowed through the company's equipment but that other solutions for after-hours prescription medication dispensing has been developed by the company for use in traditional pharmacies for access to standard medications. 

"We are pleased that Medbox is garnering so much national and international attention for our cutting-edge products and services," stated Dr. Bruce Bedrick, CEO of Medbox, Inc. "Educating the media about the differences between a "vending machine" and a "dispensing system" are a definite priority for our company."

To listen to the BBC Radio interview, simply copy and paste the link below to a web browser: https://www.dropbox.com/s/69csechyn1kqjml/BBC%20Interview.mp3

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%
US 10 Yr 2.011% -0.012

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs